Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women?
GROUND: Women with depressive symptoms may use preventive services less frequently and experience poorer health outcomes. We investigated the association of depressive symptoms with breast and colorectal cancer screening rates and stage of cancer among a cohort of postmenopausal women. METHODS: In The Women’s Health Initiative Observational Study, 93,676 women were followed on average for 7.6 years. Depressive symptoms were measured at baseline and at 3 years using the 6-item scale from the Center for Epidemiological Studies Depression scale (CES-D). We calculated a cancer screening rate expressed as a proportion of the years that women were current with recommended cancer screening over the number of follow-up visits in the study. Breast and colorectal cancers were staged based on Surveillance, Epidemiology and End Results (SEER) classification. RESULTS: At baseline, 15.8% (12,621) women were positive for depressive symptoms, and 6.9% (4,777) were positive at both baseline screening a
Related Questions
- Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women?
- Are preoperative depressive symptoms associated with postoperative delirium in geriatric surgical patients?
- Are stress-induced cortisol changes during pregnancy associated with postpartum depressive symptoms?
